TY  - JOUR 
AU  - Firvida  Perez, Jose Luis
AU  - Vázquez Estévez, Sergio
AU  - Campos Balea, Begoña
AU  - Barón Duarte, Francisco Javier
AU  - Alonso-Jaudenes Curbera, Guillermo
PY  - 2014
SN  - 0344-5704
UR  - http://hdl.handle.net/20.500.11940/6329
LA  - eng
TI  - A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.
DO  - 10.1007/s00280-013-2370-z
T2  - CANCER CHEMOTHERAPY AND PHARMACOLOGY
VL  - 73
ER  -